In particular, elevated cytoplasmic HuR presence was shown to be a marker of poor prognosis and cancer aggressiveness for bladder cancer, meningioma, lung cancer, and esophageal squamous cell carcinoma61–64. This evidence concerns the gene ELAVL1 and lung cancer.